ARCHIVES

DePinho’s Letter to CPRIT’s Gimson, And Gimson’s Response

This article is from The Cancer Letter archive.

Vol. 38 No. 22 | June 1, 2012

Download PDF Visit The Full Archive

Related Articles

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

Clinical Trials Approved By NCI CTEP Last Month

May 27, 2011

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011